Additionally, semaglutide can improve other health markers such as blood sugar control, cholesterol levels, and blood pressure, which are often associated with excess weight or obesity
Large randomized controlled trials (STEP 1, STEP 2, STEP 3) demonstrated that semaglutide at 2.4 mg weekly produces average weight loss of 1517% of baseline body weight over 68 weeks, with sustained metabolic benefits including improved blood glucose and cardiovascular risk markers
Dipeptidyl dipeptidase-4 inhibitors These drugs, consisting primarily of sitagliptin, vildagliptin, linagliptin, saxagliptin, and alogliptin, enhance the effects of incretins by inhibiting dipeptidyl dipeptidase 4 (DPP-4), the enzyme responsible for their degradation
Keep them away from light
The medication is absorbed by the blood vessels in the subcutaneous tissue and distributed throughout the body
Among them, carotene is one of the most frequently available dietary carotenoids for human consumption [142]